Selective interaction of lansoprazole and astemizole with tau polymers: potential new clinical use in diagnosis of Alzheimer's disease
about
Invited review: Frontotemporal dementia caused by microtubule-associated protein tau gene (MAPT) mutations: a chameleon for neuropathology and neuroimagingHigh affinity radiopharmaceuticals based upon lansoprazole for PET imaging of aggregated tau in Alzheimer's disease and progressive supranuclear palsy: synthesis, preclinical evaluation, and lead selectionDefensive effect of lansoprazole in dementia of AD type in mice exposed to streptozotocin and cholesterol enriched dietDrug Repositioning for Cancer Therapy Based on Large-Scale Drug-Induced Transcriptional SignaturesDementia, Preclinical Studies in Neurodegeneration and its Potential for Translational Medicine in South AmericaComparison of New Tau PET-Tracer Candidates With [18F]T808 and [18F]T807Unique drug screening approach for prion diseases identifies tacrolimus and astemizole as antiprion agentsFrequent and symmetric deposition of misfolded tau oligomers within presynaptic and postsynaptic terminals in Alzheimer's disease.Evaluation of [(11)C]N-Methyl Lansoprazole as a Radiopharmaceutical for PET Imaging of Tau Neurofibrillary Tangles.The proton-pump inhibitor lansoprazole enhances amyloid beta production.Tau PET imaging: present and future directions.Advances in tau-based drug discovery.The Co-chaperone BAG2 Mediates Cold-Induced Accumulation of Phosphorylated Tau in SH-SY5Y Cells.PET Radioligands for Imaging of Tau Pathology: Current Status.Risk of dementia from proton pump inhibitor use in Asian population: A nationwide cohort study in Taiwan.Ligand electronic properties modulate tau filament binding site densityProton Pump Inhibitors and Risk of Mild Cognitive Impairment and Dementia.Non human primate models for Alzheimer's disease-related research and drug discovery.Proton pump inhibition increases rapid eye movement sleep in the rat.Development of tau PET Imaging Ligands and their Utility in Preclinical and Clinical Studies.Novel PET/SPECT probes for imaging of tau in Alzheimer's disease.Proton Pump Inhibitors and Dementia: Physiopathological Mechanisms and Clinical Consequences.
P2860
Q27020981-1CFD0EF9-026E-4ED3-BC5C-C13769E96546Q28241366-CEC9B547-128F-40DB-B6E4-D7089C14F655Q28535014-31B7BEDB-9FD2-4993-AF51-92FB558661DEQ28550603-EB27EF8D-C461-4E54-8D63-3B1E6CA4F7D2Q28817091-02BB5463-9A1C-49D2-9CE8-DC7EA0B399ACQ33795224-64582893-0C38-4085-8009-C0366043DA72Q34036311-524C5234-D99F-4EF2-898E-0DB4A210FAB2Q34402143-33C9F3A6-D353-47D5-9AF3-866724D54916Q34423050-697965BE-D552-4BE1-B3F2-090D1A188E4EQ34631939-A8EFFE6C-FB36-4AB7-8154-F1EE69DA6E3CQ34680852-F2CB73B0-D09D-45CE-AF2D-A7218B9ACEA0Q35321539-C7B9419A-AD65-4B25-AE4B-2D9B074DC91EQ35712546-5E8DA370-3E71-4A53-A9DF-F873BC47745BQ36241261-D79B4D63-C0D3-4863-98A5-BF1FF1EA0791Q36281192-2F894BFD-C849-4746-98B6-32E3A72E3315Q36368413-CC999351-D9F8-44A1-B7F6-C024221F29B6Q38738847-45734500-76E6-4CE1-B8DB-4AABE8836E47Q38783343-92B77C8D-F69D-49C1-B878-107F83ABF00FQ42413703-4DA3CDC9-0B87-49DA-92FC-CAD3DB9109EEQ47824973-9BBAEFD9-8387-482E-8C65-7324FC8319C1Q53014962-E380C769-98D4-46A0-8784-ADD274352786Q55362855-6B48EEAA-F664-4033-9EFF-C43EF178AAC7
P2860
Selective interaction of lansoprazole and astemizole with tau polymers: potential new clinical use in diagnosis of Alzheimer's disease
description
2010 nî lūn-bûn
@nan
2010 թուականին հրատարակուած գիտական յօդուած
@hyw
2010 թվականին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Selective interaction of lanso ...... agnosis of Alzheimer's disease
@ast
Selective interaction of lanso ...... agnosis of Alzheimer's disease
@en
Selective interaction of lanso ...... agnosis of Alzheimer's disease
@nl
type
label
Selective interaction of lanso ...... agnosis of Alzheimer's disease
@ast
Selective interaction of lanso ...... agnosis of Alzheimer's disease
@en
Selective interaction of lanso ...... agnosis of Alzheimer's disease
@nl
prefLabel
Selective interaction of lanso ...... agnosis of Alzheimer's disease
@ast
Selective interaction of lanso ...... agnosis of Alzheimer's disease
@en
Selective interaction of lanso ...... agnosis of Alzheimer's disease
@nl
P2093
P2860
P356
P1476
Selective interaction of lanso ...... agnosis of Alzheimer's disease
@en
P2093
Iván N Saavedra
Jans Alzate-Morales
Leonel E Rojo
Peter Davies
Ricardo B Maccioni
P2860
P304
P356
10.3233/JAD-2010-1262
P407
P577
2010-01-01T00:00:00Z